Fil Maximilien

As I embark on my third year of a thesis in therapeutic chemistry on the identification of...

ECOSOM

One Health

Hello, my name is Maximilien Fil,

As I embark on my third year of a thesis in therapeutic chemistry on the identification of new anti-tuberculosis agents using a 3D QSAR approach, I am also embarking on an entrepreneurial adventure with the creation of a deep-tech start-up in analytical chemistry based on the creation of calibrant mixtures for (U)HPLC-MS. These mixtures help to identify problems in HPLC, whether related to the chromatographic apparatus, the column or the sample, and can be used to realign shifted analyses via a peak output covering the entire chromatogram.

But my commitment doesn't stop there! After discovering the BiotechnoSUD Forum in 2022, I joined the organisation in 2023 as Programme Manager, then in 2024 as President of the Bio'M Association. This year, I'm continuing this exciting mission.

  • 2021 - M1 Trainee - MCT, UMR_MD1, Faculty of Pharmacy, AMU
  • 2022 - M2 Intern - ICR, LPCR, UMR_7273, Faculty of Pharmacy, AMU
  • 2022-2025 - PhD Student - MCT, UMR_MD1, Faculty of Pharmacy, AMU then IMBE, ECSOM, UMR7263
  • 2023-2025 - Chairman - Biotechno Marseille (Bio'M)
  • 2020 - Degree in Physics and Chemistry - University of Toulon
  • 2021 - Master 1 Health Engineering, Medicines and Health Products - AMU
  • 2022 - Master 2 Health Engineering, Medicines and Health Products: Drug Design specialism - AMU
- Marion Casanova, Maximilien Fil, Yuxi Zhao, Nadine Azas, Sébastien Redon, et al. Efficient Synthesis of Aminoquinolinium and Aminoquinazolinium Salt Series: Amination or N-Alkylation First? SYNLETT, 2023, 34 (14), pp.1685-1688. ff10.1055/s-0042-1751465ff. ffhal-04275066. - Fil, Maximilien, and Sandrine Alibert. 2024. "Unveiling DprE1 as a Key Target in the Fight against Tuberculosis: Insights and Perspectives on Developing Novel Antimicrobial Agents" BioMed 4, no. 3: 220-236. https://doi.org/10.3390/biomed4030018.
  • Organic Chemistry
  • Machine Learning

Currently in the third year of my PhD, I'm working on 3D-QSAR models to identify new anti-tuberculosis agents targeting InhA and DprE1. I am also working on organic synthesis to optimise these compounds.

At the same time, I'm creating a Deeptech start-up based on the development of a mixture of calibrants for (U)HPLC-MS.

Publications